Proven Science. Empowered Solutions.
Who we are
Almatica, a division of Alvogen, is a privately held specialty pharmaceuticals company that is focused on developing innovative medicines.
Our portfolio is concentrated within the therapeutic areas of psychiatry and neurology. We are dedicated to developing and improving medications in these therapeutic areas as well as in adjacent diseases affecting the central nervous system.
Our guiding pillars
We are guided by pillars that shape who we are and what we stand for. Our focus on Integrity, Science, Empathy and Evolution frames our approach as we work to provide better solutions to patient needs.
Our CNS portfolio
The Almatica CNS portfolio consists of products that address mental health and neurologic conditions.
Patient support
To help a patient’s ability to afford and stay on their prescribed medications, Almatica provides patient copay savings programs for several of its products.
Meet our management
The leadership team consists of leaders who are dedicated to fostering a dynamic change-driven culture committed to meeting the needs of our customers. Our organizational structure is lean and flexible, driving quick and effective decision making and the enabling the company to bring new products quickly and safely to market.
Pipeline
Our pipeline is powered by end-to-end research and development capabilities, and our commitment to operational excellence and patient safety ensures we consistently produce the highest-quality medicines
